Ge Lou

883 total citations · 1 hit paper
27 papers, 595 citations indexed

About

Ge Lou is a scholar working on Molecular Biology, Cancer Research and Reproductive Medicine. According to data from OpenAlex, Ge Lou has authored 27 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 10 papers in Cancer Research and 6 papers in Reproductive Medicine. Recurrent topics in Ge Lou's work include Ovarian cancer diagnosis and treatment (6 papers), Ubiquitin and proteasome pathways (6 papers) and Cancer-related molecular mechanisms research (6 papers). Ge Lou is often cited by papers focused on Ovarian cancer diagnosis and treatment (6 papers), Ubiquitin and proteasome pathways (6 papers) and Cancer-related molecular mechanisms research (6 papers). Ge Lou collaborates with scholars based in China, Greece and United States. Ge Lou's co-authors include Tianbo Liu, Chang Yang, Mingzhu Yin, Yanan Pi, Mei‐Yin Zhang, Yongjian Zhang, Ye Xu, Shenghan Lou, Tingting Ge and Yan Hou and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Cell Death and Differentiation.

In The Last Decade

Ge Lou

24 papers receiving 591 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bromodomain and extraterminal (BET) proteins: biological functions, diseases and targeted therapy

2023 94 citations Zhiqiang Wang, Yuyang Wu et al. Signal Transduction and Targeted Therapy profile →

Peers

Ge Lou

MB

CR

ONCOL

IMMUN

RM

Zhihong Ai China

Chae Young Han Canada

Junli Deng China

Katharina Malinowsky Germany

Rosario Avolio Italy

Sufang Wu China

Sundersingh Shirley India

Mitzi Aguilar United States

Florence Giffard France

Himavanth R. Gatla United States

Zhihong Ai China

Ge Lou

427 ×0.9

MB

275 ×1.2

CR

117 ×1.1

ONCOL

88 ×1.3

IMMUN

65 ×1.4

RM

Citations per year, relative to Ge Lou Ge Lou (= 1×) peers Zhihong Ai

Countries citing papers authored by Ge Lou

Since Specialization

Citations

This map shows the geographic impact of Ge Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ge Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ge Lou more than expected).

Fields of papers citing papers by Ge Lou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ge Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ge Lou. The network helps show where Ge Lou may publish in the future.

Co-authorship network of co-authors of Ge Lou

This figure shows the co-authorship network connecting the top 25 collaborators of Ge Lou. A scholar is included among the top collaborators of Ge Lou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ge Lou. Ge Lou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Li, Yan, et al.. (2024). m6A methylation-mediated regulation of LncRNA MEG3 suppresses ovarian cancer progression through miR-885-5p and the VASH1 pathway. Journal of Translational Medicine. 22(1). 113–113. 8 indexed citations

2.

Lou, Shenghan, Wei Huang, Jian Li, et al.. (2024). Clinical and prognostic significance of FBXL6 expression in ovarian cancer. Gene. 933. 148978–148978.

3.

Peng, Peng, Danbo Wang, Ninghai Cheng, et al.. (2024). A real-world, patient-reported outcomes study in patients with platinum-sensitive recurrent ovarian cancer receiving long-term maintenance therapy with niraparib.. Journal of Clinical Oncology. 42(16_suppl). e23164–e23164.

4.

Yang, Chang, et al.. (2023). CBL0137 activates ROS/BAX signaling to promote caspase-3/GSDME-dependent pyroptosis in ovarian cancer cells. Biomedicine & Pharmacotherapy. 161. 114529–114529. 23 indexed citations

5.

Wang, Zhiqiang, Yuyang Wu, Yanan Pi, et al.. (2023). Bromodomain and extraterminal (BET) proteins: biological functions, diseases and targeted therapy. Signal Transduction and Targeted Therapy. 8(1). 420–420. 94 indexed citations breakdown →

6.

Tan, Shu, et al.. (2023). Hypoxic tumour-derived exosomal miR-1225-5p regulates M2 macrophage polarisation via toll-like receptor 2 to promote ovarian cancer progress. Autoimmunity. 56(1). 2281226–2281226. 6 indexed citations

7.

Pi, Yanan, et al.. (2023). Loss of SMURF2 expression enhances RACK1 stability and promotes ovarian cancer progression. Cell Death and Differentiation. 30(11). 2382–2392. 17 indexed citations

8.

Wang, Xiaoyan, Yiwen Wang, Xu Yang, et al.. (2022). Novel LncRNA ZFHX4-AS1 as a Potential Prognostic Biomarker That Affects the Immune Microenvironment in Ovarian Cancer. Frontiers in Oncology. 12. 945518–945518. 12 indexed citations

9.

Zhang, Mei‐Yin, et al.. (2021). Circular RNA circE2F2 promotes malignant progression of ovarian cancer cells by upregulating the expression of E2F2 protein via binding to HuR protein. Cellular Signalling. 84. 110014–110014. 24 indexed citations

10.

Guo, Junnan, Ning Zhang, Zhiqiang Wang, et al.. (2021). Identification and Validation of Immune-Related Gene for Predicting Prognosis and Therapeutic Response in Ovarian Cancer. Frontiers in Immunology. 12. 763791–763791.

11.

Zhang, Fan, Yuanyuan Zhang, Chaofu Ke, et al.. (2018). Predicting ovarian cancer recurrence by plasma metabolic profiles before and after surgery. Metabolomics. 14(5). 65–65. 21 indexed citations

12.

Xu, Ye, Jiawei Yu, Tianbo Liu, et al.. (2016). Loss of FBXW7 is related to the susceptibility and poor prognosis of cervical squamous carcinoma. Biomarkers. 21(4). 379–385. 13 indexed citations

13.

Fan, Lijun, Mingzhu Yin, Chaofu Ke, et al.. (2016). Use of Plasma Metabolomics to Identify Diagnostic Biomarkers for Early Stage Epithelial Ovarian Cancer. Journal of Cancer. 7(10). 1265–1272. 34 indexed citations

14.

Yin, Mingzhu, Xia Li, Yan Hou, et al.. (2015). Identification of phosphatidylcholine and lysophosphatidylcholine as novel biomarkers for cervical cancers in a prospective cohort study. Tumor Biology. 37(4). 5485–5492. 42 indexed citations

15.

Yang, Meng, Yunduo Liu, Yanying Wang, et al.. (2013). Ubiquitin-specific protease 22: a novel molecular biomarker in cervical cancer prognosis and therapeutics. Tumor Biology. 35(2). 929–934. 30 indexed citations

16.

Gao, Hongyu, Ge Lou, Lina Gu, et al.. (2013). TNFAIP8 as a predictor of metastasis and a novel prognostic biomarker in patients with epithelial ovarian cancer. British Journal of Cancer. 109(6). 1685–1692. 47 indexed citations

17.

Meng, Fanling, et al.. (2013). LAPTM4Bgene polymorphism and endometrial carcinoma risk and prognosis. Biomarkers. 18(2). 136–143. 12 indexed citations

18.

Fan, Lijun, Wang Zhang, Mingzhu Yin, et al.. (2012). Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform. Acta Oncologica. 51(4). 473–479. 60 indexed citations

19.

Meng, Fanling, Yuanlong Hu, Mingzhu Yin, et al.. (2010). Overexpression of LAPTM4B-35 in Cervical Carcinoma. International Journal of Gynecological Pathology. 29(6). 587–593. 24 indexed citations

20.

Gao, Yuyan, et al.. (2010). DNA methylation of the RIZ1 tumor suppressor gene plays an important role in the tumorigenesis of cervical cancer. European journal of medical research. 15(1). 20–20. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact